+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopolymers for Medical Applications Market by Application, Type, Form, End User, Production Method - Global Forecast to 2030- Product Image
Biopolymers for Medical Applications Market by Application, Type, Form, End User, Production Method - Global Forecast to 2030- Product Image
Sale

Biopolymers for Medical Applications Market by Application, Type, Form, End User, Production Method - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829857
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopolymers for Medical Applications Market grew from USD 3.00 billion in 2024 to USD 3.73 billion in 2025. It is expected to continue growing at a CAGR of 23.30%, reaching USD 10.55 billion by 2030.

Pioneering Biopolymers in Medical Innovation

The rapidly evolving field of medical-grade biopolymers stands at the intersection of materials science and healthcare innovation. Advances in polymer chemistry have yielded a new generation of biocompatible and biodegradable materials designed to meet the stringent demands of clinical applications. From implantable cardiovascular devices to sophisticated tissue engineering scaffolds, these polymers are redefining the standards of safety, efficacy, and patient outcomes.

This introduction outlines the critical context for understanding current market dynamics. Regulatory bodies worldwide are converging on unified guidelines that balance accelerated approval pathways with rigorous post-market surveillance. Concurrently, growing investment in personalized medicine and minimally invasive procedures has catalyzed demand for tailored polymer formulations. As we navigate through the subsequent sections, readers will gain clarity on the disruptive forces reshaping production, segmentation, regional adoption, and strategic imperatives.

By grounding our analysis in the latest industry reports and stakeholder interviews, this overview establishes a foundation for deeper exploration. The ensuing narrative highlights transformative shifts, trade policy impacts, segmentation nuances, regional trends, competitive positioning, and actionable recommendations. This structured approach ensures that decision-makers and technical experts alike can derive maximum value from the insights presented.

Catalysts Driving a New Era in Medical Polymers

Recent years have witnessed a convergence of breakthrough research and market acceleration in the medical biopolymers landscape. Novel manufacturing techniques have enabled greater control over polymer architecture, fostering materials with precisely tuned degradation rates and mechanical properties. This evolution has propelled applications ranging from drug-eluting films to advanced wound dressings.

Simultaneously, interdisciplinary collaborations between biomaterials scientists, clinicians, and regulatory agencies have streamlined translation from bench to bedside. Such partnerships have fostered the rapid prototyping of electrospun scaffolds for bone regeneration and hyaluronic acid-based hydrogels for ophthalmic repairs. The result is a pipeline of next-generation products that address unmet clinical needs while minimizing adverse reactions.

Moreover, sustainability considerations have gained traction, inspiring producers to adopt greener extraction and fermentation processes. The emphasis on circular economy principles is reshaping the supply chain, prompting stakeholders to reevaluate raw material sourcing and end-of-life strategies. This transformative ecosystem sets the stage for unparalleled growth and innovation in the years ahead.

Navigating the Impact of US Tariffs on Biopolymer Trade

The imposition of new cumulative tariffs by the United States in 2025 has introduced fresh complexities in global biopolymer trade. Import duties on select raw and semi-processed polymer inputs have elevated production costs, compelling manufacturers to reassess sourcing strategies and contractual frameworks. In response, several leading producers have initiated dual-sourcing agreements and nearshoring initiatives to mitigate duties and currency volatility.

These tariff pressures have also accelerated efforts to localize high-value manufacturing activities. Investment in domestic fermentation facilities and chemical synthesis plants has gained momentum, supported by government incentives aimed at bolstering supply chain resilience. Fragmented segments, such as polylactic acid and chitosan derivatives, have witnessed particular interest from capital markets as stakeholders seek to reduce exposure to cross-border levies.

Despite the immediate cost headwinds, the long-term effect of these trade policies may prove constructive. By fostering a more regionally diversified manufacturing footprint, the ecosystem becomes less susceptible to single-point disruptions. Companies that proactively adapt to this evolving trade environment stand to secure stronger competitive positions and foster sustainable growth.

Unveiling Market Dynamics Through Strategic Segmentation

Our segmentation analysis reveals distinct value pools across medical applications, material types, physical forms, end-user profiles, and production methods. In the realm of application, cardiovascular devices and dental solutions command premium performance standards, while drug delivery systems leverage polymer films, microspheres, and nanoparticles to achieve precise therapeutic release profiles. Tissue engineering innovations in bone, cartilage, and skin matrices coexist with expanding portfolios of ophthalmic, orthopedic, suture, and wound dressing products.

When examining polymer types, alginate, chitosan, collagen, hyaluronic acid, polyhydroxyalkanoates, and polylactic acid each address unique biomedical demands. The subdivision of polyhydroxyalkanoates into PHB and PHV highlights nuanced trade-offs between mechanical strength and degradation kinetics. Across various physical forms-fibers, films, hydrogels, microspheres, and scaffolds-the distinction between electrospun and printed scaffold architectures is driving tailored regenerative medicine solutions.

End-user segmentation uncovers differentiated adoption patterns among contract research organizations, hospitals and clinics, pharmaceutical companies, and research laboratories. Meanwhile, production method insights from chemical synthesis, extraction, and fermentation underscore both traditional and cutting-edge manufacturing modalities. Together, this layered segmentation framework illuminates strategic pathways for resource allocation and market entry.

Regional Variations Shaping Biopolymer Adoption

Regional dynamics within the biopolymer medical market illustrate divergent growth vectors and regulatory environments. In the Americas, robust investment in advanced healthcare infrastructure and a track record of early technology adoption have catalyzed strong uptake of next-generation polymer implants and drug delivery systems. Stakeholders in North America prioritize compliance with stringent FDA guidelines, while Latin American markets exhibit increasing interest in cost-effective wound care and tissue repair solutions.

Europe, Middle East & Africa present a mosaic of regulatory frameworks and funding landscapes. European Union directives on medical device safety and biocompatibility have fostered a collaborative research ecosystem, resulting in a pipeline of CE-marked biopolymer products. Gulf Cooperation Council initiatives are channeling capital into state-of-the-art manufacturing facilities, and Sub-Saharan programs are leveraging biopolymers for affordable healthcare innovations in resource-constrained settings.

In Asia-Pacific, rapid population growth and expanding healthcare access are fueling demand across all polymer categories. Regional manufacturing hubs in China, India, Japan, and South Korea benefit from integrated value chains, advanced fermentation technology, and government subsidies that support scale-up. This convergence of policy support and market demand positions the region as a key driver of future growth.

Leading Forces in the Biopolymer Medical Sector

A competitive analysis highlights the roles of established chemical enterprises, specialized biomaterials firms, and innovative startups. Leading global players leverage expansive R&D budgets and integrated manufacturing networks to optimize production efficiency and ensure regulatory compliance. These incumbents maintain deep pipelines of proprietary formulations and maintain strategic partnerships with academic institutions to sustain technological leadership.

Mid-tier companies focus on niche applications and agile production capabilities, carving out value in segments such as ophthalmic films and tissue scaffold fabrication. Their flexibility in customizing polymers for localized market requirements affords them a distinct advantage in responding to emerging clinical trends. Simultaneously, venture-backed startups are disrupting traditional development cycles by pioneering bio-inspired polymers and rapid prototyping techniques that compress time-to-market.

Across this competitive landscape, collaboration and consolidation are prevalent themes. Joint ventures and licensing agreements facilitate the co-development of next-generation biopolymers, while strategic acquisitions enable players to expand capacities and diversify their product portfolios. Companies that exhibit both technological prowess and operational agility are poised to capture the highest value.

Strategic Imperatives for Biopolymer Industry Leaders

Industry leaders must adopt a multi-pronged strategy to secure long-term success. First, strengthening supply chain resilience through diversified sourcing and localized production will mitigate risks associated with trade policy fluctuations. Investment in modular manufacturing platforms, capable of switching between chemical synthesis and bioprocessing routes, will enhance responsiveness to market shifts.

Second, forging collaborations across the value chain-from academic research centers to clinical end users-will accelerate innovation and validation. Co-development agreements that align polymer performance characteristics with specific patient outcomes can differentiate product offerings and justify premium pricing. Simultaneously, embedding sustainability metrics into material selection and production workflows will meet growing demand for greener healthcare solutions.

Finally, leveraging advanced analytics and digital twins can optimize scale-up processes and reduce time-to-market. By integrating process data with predictive models of polymer behavior and device performance, companies can proactively troubleshoot manufacturing challenges and expedite regulatory submissions. This blend of operational excellence and scientific rigor will position organizations to lead in the dynamic biopolymer ecosystem.

Rigorous Methodology Underpinning Market Insights

Our research methodology synthesizes primary interviews, secondary data, and rigorous qualitative analysis. Interviews with key stakeholders-ranging from materials scientists and regulatory specialists to procurement executives-provided actionable intelligence on technical challenges and market opportunities. These insights were cross-validated against publicly available sources, including patent databases, clinical trial registries, and governmental policy documents.

Secondary research encompassed a comprehensive review of peer-reviewed journals, industry white papers, and conference proceedings. Where appropriate, trade association publications and clinical guidelines were consulted to ensure alignment with current best practices. Throughout the analysis, methodological rigor was maintained by applying a consistent framework for data triangulation, ensuring that conclusions rest on robust evidence rather than anecdotal observations.

The final report integrates these findings into thematic narratives and decision-support tools. Segmentation matrices, competitive benchmarking, and regional heat maps enable stakeholders to extract targeted insights. By adhering to transparent documentation standards, readers can trace the provenance of each data point and replicate analytical pathways if desired.

Synthesis of Biopolymer Trends and Market Outlook

In conclusion, the medical biopolymers market stands poised for significant transformation driven by technological innovation, regulatory evolution, and strategic realignments. The diversity of polymer types and application areas presents abundant opportunities for differentiation, yet requires careful orchestration of supply chain, regulatory, and commercial strategies. Stakeholders who navigate these complexities with foresight and agility will shape the future of patient care.

As trade policies and regional adoption patterns continue to evolve, companies must remain vigilant, continuously adjusting their production footprints and partnership networks. Robust segmentation analysis and competitive intelligence form the backbone of informed decision-making, guiding resource allocation and product development priorities. Ultimately, success in this dynamic environment hinges on the ability to integrate scientific excellence with operational discipline and market insight.

The insights presented throughout this executive summary deliver a roadmap for industry leaders seeking to harness the full potential of biopolymers in medical applications. By coupling strategic vision with tactical execution, organizations can achieve sustainable growth and deliver transformative patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Cardiovascular Devices
    • Dental Applications
    • Drug Delivery
      • Films
      • Microspheres
      • Nanoparticles
    • Ophthalmic Devices
    • Orthopedic Devices
    • Surgical Sutures
    • Tissue Engineering
      • Bone Tissue
      • Cartilage
      • Skin Tissue
    • Wound Dressing
  • Type
    • Alginate
    • Chitosan
    • Collagen
    • Hyaluronic Acid
    • Polyhydroxyalkanoates
      • Phb
      • Phv
    • Polylactic Acid
  • Form
    • Fibers
    • Films
    • Hydrogels
    • Microspheres
    • Scaffolds
      • Electrospun Scaffolds
      • Printed Scaffolds
  • End User
    • Contract Research Organizations
    • Hospitals And Clinics
    • Pharmaceutical Companies
    • Research Laboratories
  • Production Method
    • Chemical Synthesis
    • Extraction
    • Fermentation
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Evonik Industries AG
  • Corbion N.V.
  • NatureWorks LLC
  • Cargill, Incorporated
  • DuPont de Nemours, Inc.
  • Koninklijke DSM N.V.
  • Tepha, Inc.
  • Poly-Med, Inc.
  • Sigma-Aldrich Corporation
  • Danimer Scientific, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopolymers for Medical Applications Market, by Application
8.1. Introduction
8.2. Cardiovascular Devices
8.3. Dental Applications
8.4. Drug Delivery
8.4.1. Films
8.4.2. Microspheres
8.4.3. Nanoparticles
8.5. Ophthalmic Devices
8.6. Orthopedic Devices
8.7. Surgical Sutures
8.8. Tissue Engineering
8.8.1. Bone Tissue
8.8.2. Cartilage
8.8.3. Skin Tissue
8.9. Wound Dressing
9. Biopolymers for Medical Applications Market, by Type
9.1. Introduction
9.2. Alginate
9.3. Chitosan
9.4. Collagen
9.5. Hyaluronic Acid
9.6. Polyhydroxyalkanoates
9.6.1. Phb
9.6.2. Phv
9.7. Polylactic Acid
10. Biopolymers for Medical Applications Market, by Form
10.1. Introduction
10.2. Fibers
10.3. Films
10.4. Hydrogels
10.5. Microspheres
10.6. Scaffolds
10.6.1. Electrospun Scaffolds
10.6.2. Printed Scaffolds
11. Biopolymers for Medical Applications Market, by End User
11.1. Introduction
11.2. Contract Research Organizations
11.3. Hospitals And Clinics
11.4. Pharmaceutical Companies
11.5. Research Laboratories
12. Biopolymers for Medical Applications Market, by Production Method
12.1. Introduction
12.2. Chemical Synthesis
12.3. Extraction
12.4. Fermentation
13. Americas Biopolymers for Medical Applications Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biopolymers for Medical Applications Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biopolymers for Medical Applications Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Evonik Industries AG
16.3.2. Corbion N.V.
16.3.3. NatureWorks LLC
16.3.4. Cargill, Incorporated
16.3.5. DuPont de Nemours, Inc.
16.3.6. Koninklijke DSM N.V.
16.3.7. Tepha, Inc.
16.3.8. Poly-Med, Inc.
16.3.9. Sigma-Aldrich Corporation
16.3.10. Danimer Scientific, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET MULTI-CURRENCY
FIGURE 2. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET MULTI-LANGUAGE
FIGURE 3. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SURGICAL SUTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY BONE TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SKIN TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY WOUND DRESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY ALGINATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHB, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHV, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FIBERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY ELECTROSPUN SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRINTED SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 73. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 126. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 128. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 129. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 131. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. GERMANY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 135. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 137. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 138. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 140. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 141. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. FRANCE BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 153. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 155. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 156. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 158. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 159. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 160. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 162. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 164. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 165. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 167. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 198. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 200. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 201. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 203. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 204. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. DENMARK BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 216. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 218. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 219. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 221. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 223. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. QATAR BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 225. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 228. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 230. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 232. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. FINLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 252. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 254. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 255. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 257. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 258. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 259. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. EGYPT BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 263. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 264. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 266. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 267. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 268. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. TURKEY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 279. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 281. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 282. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 283. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 284. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 285. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 286. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. NORWAY BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY PRODUCTION METHOD, 2018-2030 (USD MILLION)
TABLE 288. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 290. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 291. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 292. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY POLYHYDROXYALKANOATES, 2018-2030 (USD MILLION)
TABLE 293. POLAND BIOPOLYMERS FOR MEDICAL APPLICATIONS MARKET SIZE, BY FORM, 2018-2030 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biopolymers for Medical Applications market report include:
  • Evonik Industries AG
  • Corbion N.V.
  • NatureWorks LLC
  • Cargill, Incorporated
  • DuPont de Nemours, Inc.
  • Koninklijke DSM N.V.
  • Tepha, Inc.
  • Poly-Med, Inc.
  • Sigma-Aldrich Corporation
  • Danimer Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.55 Billion
Compound Annual Growth Rate23.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biopolymers Market by Type, Application, End Use Industry, Process Type - Global Forecast to 2030 - Product Image

Biopolymers Market by Type, Application, End Use Industry, Process Type - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Aerobically Degradable Biopolymer Market by Application, Type, End Use, Form, Production Process - Global Forecast to 2030 - Product Image

Aerobically Degradable Biopolymer Market by Application, Type, End Use, Form, Production Process - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Bioplastics and Biopolymers - Global Strategic Business Report - Product Image

Bioplastics and Biopolymers - Global Strategic Business Report

  • Report
  • 452 Pages
  • Global
From
Lignin-based Biopolymers Market Size, Share & Trends Analysis Report by Product Type (Lignosulfonates, Kraft Lignin, Organosolv Lignin, Hydrolyzed Lignin), End-use (Automotive, Construction, Packaging, Agriculture), Region, with Growth Forecasts, 2025-2030 - Product Image

Lignin-based Biopolymers Market Size, Share & Trends Analysis Report by Product Type (Lignosulfonates, Kraft Lignin, Organosolv Lignin, Hydrolyzed Lignin), End-use (Automotive, Construction, Packaging, Agriculture), Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Polymers & Biopolymers In Beauty & Personal Care Products Market Size, Share & Trends Analysis Report By Function (Conditioning, Styling, Rheology Modifying), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Polymers & Biopolymers In Beauty & Personal Care Products Market Size, Share & Trends Analysis Report By Function (Conditioning, Styling, Rheology Modifying), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 145 Pages
  • Global
From

About the Medical Biopolymer Market

Medical biopolymers are bioplastics used in the medical industry. They are biodegradable, biocompatible, and non-toxic materials that can be used in a variety of medical applications, such as implants, prosthetics, and drug delivery systems. Medical biopolymers are typically derived from renewable sources, such as corn, sugarcane, and other plant-based materials. They are also often used in combination with other materials, such as metals, ceramics, and polymers, to create more complex medical devices. Medical biopolymers offer a number of advantages over traditional materials, such as improved biocompatibility, reduced risk of infection, and improved durability. They are also more cost-effective than traditional materials, making them attractive to medical device manufacturers. Some of the major companies in the medical biopolymer market include BASF, DowDuPont, Corbion, NatureWorks, and Novamont. These companies produce a variety of biopolymers for medical applications, including polylactic acid, polyhydroxyalkanoates, and polycaprolactone. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.